Invest in Novavax, Inc. , you can buy Novavax, Inc. stock in any dollar amount, or any other fund or stock you know on Stash.
Who owns the most Novavax stock?
Stockholder Stake Shares owned
--------------------------- ----- ------------
The Vanguard Group, Inc. 8.83% 6,678,644
BlackRock Fund Advisors 4.80% 3,628,869
RA Capital Management LP 2.78% 2,097,794
SSgA Funds Management, Inc. 2.31% 1,746,627
What is Nvax new price target?
High $315.00
------------- -------
Median $266.00
Low $150.00
Average $250.00
Current Price $82.92
Should I buy NLST stock?
The consensus among Wall Street equities research analysts is that investors should "buy" Netlist stock.
Will NLST go up?
Based on our forecasts, a long-term increase is expected, the "NLST" stock price prognosis for 2027-01-22 is 10.457 USD. With a 5-year investment, the revenue is expected to be around +106.66%. Your current $100 investment may be up to $206.66 in 2027.
Will Netlist stock go up?
Fair opening price Current price
----------------------------------- ------------------
$5.01 $5.06 (Overvalued)
What ETFS does Novavax hold?
Mutual fund Stake Total change
------------------------------------ ----- ------------
iShares Biotechnology ETF 0.78% -0.46%
American Funds Growth Fund of Ame 0.68% -58.85%
American Funds Small Cap World Fu 0.54% 0.00%
Fidelity Extended Market Index Fu 0.51% +1.07%
What is the prediction for Novavax stock?
Fundamental Analysis Of NVAX Stock For 2021, NVAX stock analysts polled by FactSet expect the company to lose $12.56 per share. That could swing to a $29.31 gain next year, assuming the company broadly launches its Covid vaccine. Analysts also expect $1.37 billion in 2021 revenue to grow to $4.94 billion in 2022.4 days ago
Is NVAX a good stock?
NVAX stock has a Composite Rating of 4 out of a best-possible 99. The Composite Rating is a 1-99 measure of a stock's technical and fundamental growth metrics. On this measure, NVAX stock ranks in the bottom 4% of all stocks. Shares also have a low EPS Rating of 6.4 days ago